Fundraising Fox
Enantios
Switzerland, CH · 3 known investors
Find your way into Enantios
Sign up to see every warm intro you have to Enantios
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Enantios team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Enantios provides structural measurement services for molecules and proteins, as well as selling ROA (Raman Optical Activity) instruments for molecular characterization. The company serves researchers and companies working with chiral molecules, proteins, and antibodies.
Founders & leadership
MD
Monika DenglerCTO Co-FounderMonika Dengler is a pharmacist with six years of industry experience in medical device development and biological evaluation, bringing expertise in pharmaceutical and medical device regulations and quality assurance.
Investors · 3
Privilège Ventureslisted by Privilège VenturesLugano · $100K – $1M
How we know: Privilège Ventures's portfolio page · a partner's Signal profile · the VCSheet dataset · Not right? Tell us
Also in the syndicate · 1
Privilege Ventureslead
Frequently asked questions
- What does Enantios do?
- Enantios provides structural measurement services for molecules and proteins, as well as selling ROA (Raman Optical Activity) instruments for molecular characterization. The company serves researchers and companies working with chiral molecules, proteins, and antibodies.
- Who founded Enantios?
- Enantios was founded by Roman Wyss, Monika Dengler.
- Who are Enantios's investors?
- Enantios's investors include Privilège Ventures, S2S Ventures.
- Where is Enantios headquartered?
- Enantios is headquartered in Switzerland, CH.